LSL Pharma Group, Inc. (LSL.V)
0.30
0.00 (0.00%)
CAD |
TSXV |
Oct 08, 16:00
LSL Pharma Group Profit Margin (Quarterly) : -15.33% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -15.33% |
| March 31, 2026 | -22.90% |
| December 31, 2025 | -14.96% |
| September 30, 2025 | -15.58% |
| June 30, 2025 | -5.39% |
| March 31, 2025 | -2.34% |
| December 31, 2024 | 83.55% |
| Date | Value |
|---|---|
| September 30, 2024 | -9.63% |
| June 30, 2024 | -12.31% |
| March 31, 2024 | -6.73% |
| December 31, 2023 | -13.76% |
| September 30, 2023 | -30.35% |
| June 30, 2023 | -50.98% |
| March 31, 2023 | -266.9% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Vitality Products, Inc. | -15.19% |
| Genix Pharmaceuticals Corp. | -- |
| Leef Brands, Inc. | -18.35% |
| NeutriSci International, Inc. | -- |
| Jamieson Wellness, Inc. | 7.96% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -29.84% |
| Return on Assets | -10.08% |
| Return on Invested Capital | -11.73% |
| Gross Profit Margin (Quarterly) | 8.95% |
| Operating Margin (Quarterly) | -7.53% |
| Return on Net Operating Assets | -10.59% |